Soc. Generale Call 115 TEL2/B 21..../ DE000SW9DEC4 /
2024-05-21 8:28:01 AM | Chg.+0.020 | Bid11:28:03 AM | Ask11:28:03 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.180EUR | +12.50% | 0.180 Bid Size: 50,000 |
0.190 Ask Size: 50,000 |
Tele2 AB ser. B | 115.00 SEK | 2025-03-21 | Call |
GlobeNewswire
1:15 PM
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
1:10 PM
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
1:07 PM
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
1:05 PM
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
1:00 PM
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
1:00 PM
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
GlobeNewswire
1:00 PM
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
1:00 PM
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
1:00 PM
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
1:00 PM
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
1:00 PM
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
1:00 PM
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
1:00 PM
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...